This educational supplement, sponsored by Guerbet, is intended for readers in the EU only. Guerbet obtained the CE mark for its conventional transarterial chemoembolization (cTACE) mixing and injection system, Vectorio, which is an all-in-one, unique, ready-to-use kit. It could also help to standardise cTACE, say interventional oncology experts.
[pdfviewer width=”100%” height=”940px” beta=”true”]https://interventionalnews.com/wp-content/uploads/sites/13/2018/06/Guerbet-Supplement-April-2018-v5_12.4_UK_PRINT-1.pdf[/pdfviewer]
